The findings underscore the essential role of CELF1 in gastric cancer cell proliferation, highlighting the potential of RNA interference-mediated CELF1 silencing as a promising therapeutic strategy for gastric cancer [95]. This evidence concerns the gene CELF1 and gastric cancer.